Document is current
Any future updates will be listed below
-
Authors
Khezri, Rojyar
Holland, Petter
Schoborg, Todd Andrew
Abramovich, Ifat
Takáts, Szabolcs
Dillard, Caroline
Jain, Ashish https://orcid.org/0000-0001-6549-2788
O'Farrell, Fergal
Schultz, Sebastian Wolfgang https://orcid.org/0000-0002-3661-2178
Hagopian, William M
Quintana, Eduardo Martin
Ng, Rachel https://orcid.org/0000-0001-8969-9628
Katheder, Nadja Sandra
Rahman, Mohammed Mahidur https://orcid.org/0000-0001-5327-4193
Teles Reis, José Gerardo
Brech, Andreas
Jasper, Heinrich
Rusan, Nasser M
Jahren, Anne Hope
Gottlieb, Eyal https://orcid.org/0000-0002-9770-0956
Rusten, Tor Erik https://orcid.org/0000-0002-9150-2676
-
Funding
Funding for this research was provided by:
The Norwegian Research Council (262652)
The Norwegian Research Council (276070)
South Eastern Norway Regional Health Authority (40041)
Division of Intramural Research at the National Institute of Health/National Heart, Lung and Blood Institute (1K22HL137902)
Division of Intramural Research at the National Institute of Health/National Heart, Lung and Blood Institute (1ZIAHL006126)
- License Information
-
More Information
Article History
Received: 3 December 2020
Revised: 14 May 2021
Accepted: 1 June 2021
First Online: 26 July 2021
Conflict of interest
: EG is a Board member and a shareholder of Metabomed Ltd, Israel. NSK and HJ are employees at Genentech, Inc.
